Darlinda M Grice, MD in Charlottesville, VA - Medicare Physical Medicine And Rehabilitation

Darlinda M Grice, MD is a medicare enrolled "Physical Medicine & Rehabilitation" physician in Charlottesville, Virginia. She went to Indiana University School Of Medicine and graduated in 1989 and has 35 years of diverse experience with area of expertise as Physical Medicine And Rehabilitation. She is a member of the group practice Ivyrehab Sept, Llc, University Of Virginia Physicians Group and her current practice location is 1910 Arlington Blvd, Charlottesville, Virginia. You can reach out to her office (for appointments etc.) via phone at (434) 243-0075.

Darlinda M Grice is licensed to practice in Virginia (license number 0101053935) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1881666345.

Contact Information

	Darlinda M Grice, MD
	1910 Arlington Blvd, Charlottesville, VA 22903-1594
	(434) 243-0075
	(434) 243-0078

Physician's Profile

Full Name	Darlinda M Grice
Gender	Female
Speciality	Physical Medicine And Rehabilitation
Experience	35 Years
Location	1910 Arlington Blvd, Charlottesville, Virginia
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Darlinda M Grice attended and graduated from Indiana University School Of Medicine in 1989

NPI Data:

NPI Number: 1881666345
Provider Enumeration Date: 02/07/2006
Last Update Date: 10/22/2020

Medicare PECOS Information:

PECOS PAC ID: 7012076615
Enrollment ID: I20081112000211

Medical Identifiers

Medical identifiers for Darlinda M Grice such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881666345	NPI	-	NPPES
452105	Other	VA	ANTHEM
34297	Other	VA	SENTARA
147154	Other	VA	SOUTHERN HEALTH
7602618	Other	VA	VA PREMIER
007602618	Medicaid	VA
1041331	Other	VA	FIRST HEALTH
700026822	Other	VA	CIGNA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	0101053935 (Virginia)	Secondary
208100000X	Physical Medicine & Rehabilitation	0101053935 (Virginia)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Virginia Medical Center	Charlottesville, VA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Ivyrehab Sept, Llc	7911990908	1137
University Of Virginia Physicians Group	4880590728	1397

News Archive

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and Aurigene Discovery Technologies Ltd., a Bangalore based fully integrated, global biotech focused on small molecule and peptide drug discovery and development from target identification and validation to pre IND drug candidates, today announced the successful nomination of a development candidate, Debio 0617, a novel inhibitor of an undisclosed oncology pathway.

Whole-exome sequencing discovers cause of glycosylation disorders

Sequencing a patient's entire genome to discover the source of his or her disease is not routine - yet. But geneticists are getting close. A case report, published this week in the American Journal of Human Genetics, shows how researchers can combine a simple blood test with an "executive summary" scan of the genome to diagnose a type of severe metabolic disease.

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Deciphera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, announced the presentation today of updated preliminary results from its ongoing Phase 1 clinical study of DCC-2618, the company's broad-spectrum KIT and PDGFRα inhibitor, in patients with gastrointestinal stromal tumors as a proffered paper presentation at the European Society of Medical Oncology 2018 Congress in Munich, Germany.

Researchers create vaccine that reduces tumors in mice

Researchers at Mayo Clinic in Arizona and the University of Georgia (UGA) have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases - including those that are resistant to common treatments.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Darlinda M Grice allows following entities to bill medicare on her behalf.

Entity Name	University Of Virginia Physicians Group
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780

News Archive

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Whole-exome sequencing discovers cause of glycosylation disorders

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Researchers create vaccine that reduces tumors in mice

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Darlinda M Grice is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Darlinda M Grice, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () -	Darlinda M Grice, MD 1910 Arlington Blvd, Charlottesville, VA 22903-1594 Ph: (434) 243-0075

News Archive

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Whole-exome sequencing discovers cause of glycosylation disorders

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Researchers create vaccine that reduces tumors in mice

Physical Medicine & Rehabilitation Doctors in Charlottesville, VA

Laura W. Lee, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 545 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-243-5600 Fax: 434-243-5639
David S. Rubendall, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 515 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-0000
Deirdre C. Kerrigan, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Lee St, Charlottesville, VA 22908 Phone: 434-924-0000
Dr. Susan A. Miller, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Uva Musculoskeletal Center, 545 Ray C. Hunt Drive, Charlottesville, VA 22903 Phone: 434-243-5600 Fax: 434-243-5639
Dr. Rachel Hallmark, M.D., PH.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 375 Four Leaf Ln Ste 202, Charlottesville, VA 22903 Phone: 434-205-4477 Fax: 434-205-4705
Brice Goode, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1490 Pantops Mountain Pl Ste 202, Charlottesville, VA 22911 Phone: 434-245-6472 Fax: 434-245-6474
Regan H. Royer, M.D., M.P.H Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 515 Ray C. Hunt Drive, Charlottesville, VA 22903 Phone: 434-243-5622 Fax: 434-243-5639

Darlinda M Grice, MD - Medicare Physical Medicine And Rehabilitation in Charlottesville, VA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Whole-exome sequencing discovers cause of glycosylation disorders

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Researchers create vaccine that reduces tumors in mice

Medicare Reassignments

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Whole-exome sequencing discovers cause of glycosylation disorders

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Researchers create vaccine that reduces tumors in mice

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Debiopharm, Aurigene commence IND enabling studies for Debio 0617 inhibitor

Whole-exome sequencing discovers cause of glycosylation disorders

Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors

Researchers create vaccine that reduces tumors in mice

Physical Medicine & Rehabilitation Doctors in Charlottesville, VA